Almost a quarter of pediatric patients with acute lymphoblastic leukemia (ALL) suffer from relapses. The biological mechanisms underlying therapy response and development of relapses have remained ...
Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study Overall results were informative regarding an LS diagnosis for 76.1% and 60.8% of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback